David M. Aboulafia

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

Joel M. Palefsky, Jeannette Y. Lee, Naomi Jay et al. · New England Journal of Medicine · 2022 · 436 citations · Full text

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

Sherry H. Stewart, H Jablonowski, F. D. Goebel et al. · Journal of Clinical Oncology · 1998 · 357 citations

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan et al. · Blood · 2009 · 255 citations · Full text

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men

Timothy Wilkin, Jeannette Y. Lee, Shelly Lensing et al. · The Journal of Infectious Diseases · 2010 · 233 citations · Full text